Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPP | AZN | AMGN | GILD | BMY |
| Company | Rapport Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 33.89 | 184.36 | 326.03 | 130.44 | 57.65 |
| High | 35.80 | 185.19 | 326.79 | 132.89 | 58.00 |
| Low | 33.83 | 183.78 | 323.21 | 130.00 | 56.93 |
| Latest | 35.06 | 184.15 | 325.51 | 132.58 | 57.39 |
| Change | +1.17 | -0.59 | -4.31 | +0.93 | -0.83 |
| % Change | +3.45% | -0.32% | -1.31% | +0.71% | -1.43% |
| Volume | 99,527 | 342,277 | 696,294 | 1,981,522 | 3,015,664 |
| 20-Day Average Volume | 334,162 | 1,973,521 | 2,478,357 | 5,238,698 | 9,581,630 |
| Previous Close | 33.89 | 184.74 | 329.82 | 131.65 | 58.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 35.53 | 195.84 | 345.11 | 135.17 | 58.64 |
| 20-Day Raw Stochastic | 41.87% | 11.89% | 2.68% | 29.21% | 7.44% |
| 20-Day Relative Strength | 56.57 | 39.58 | 35.90 | 42.20 | 45.52 |
| Weighted Alpha | +102.61 | +29.30 | +15.08 | +28.34 | +23.54 |
| Today's Opinion | 88% Buy | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 88% Buy | 24% Buy | 8% Sell | 8% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.27% since 04/27/26 | -1.46% since 04/27/26 | -4.70% since 04/27/26 | +3.42% since 04/27/26 | -0.94% since 04/27/26 |
| Low | 32.41 on 04/30/26 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.96 on 04/30/26 | 56.95 on 05/04/26 |
| High | 35.88 on 04/28/26 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 132.89 on 05/04/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | +5.14% since 04/02/26 | -9.20% since 04/02/26 | -6.83% since 04/02/26 | -5.43% since 04/02/26 | -3.97% since 04/02/26 |
| Low | 31.26 on 04/07/26 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.64 on 04/27/26 | 56.95 on 05/04/26 |
| High | 40.92 on 04/17/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +33.55% since 02/04/26 | -1.43% since 02/04/26 | -11.47% since 02/04/26 | -9.65% since 02/04/26 | -0.67% since 02/04/26 |
| Low | 25.21 on 02/05/26 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.64 on 04/27/26 | 56.45 on 03/24/26 |
| High | 40.92 on 04/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +32.48% since 11/04/25 | +12.62% since 11/04/25 | +9.26% since 11/04/25 | +7.41% since 11/04/25 | +25.54% since 11/04/25 |
| Low | 23.75 on 11/17/25 | 162.04 on 11/05/25 | 302.13 on 11/05/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 40.92 on 04/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,620,213 | 286,514,752 | 177,998,896 | 163,406,864 | 118,869,808 |
| Shares Outstanding, K | 47,808 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -111,480,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -33,760,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.82 | 0.26 | 0.44 | 0.32 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 03/10/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/14/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 15.67 | 16.05 | 10.22 |